H2020
GLIOTRAIN
Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 48 months
- Total cost
- EUR 3,836,772
- EU contribution
- EUR 3,836,772
- Participants
- 23 from 8 countries
- Topic
- H2020_MSCA-ITN-2017
- Grant agreement
- 766069
Coordinated by Royal College of Surgeons in Ireland (IEIreland).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Royal College of Surgeons in Ireland | IEIreland | Coordinator | EUR 1,062,698 | known name (0.95) |
| Agilent Technologies Belgium NV | BEBelgium | Participant | EUR 84,007 | PIC (1.00) |
| Katholieke Universiteit Leuven | BEBelgium | Partner | EUR 0 | PIC (1.00) |
| Oncurious NV | BEBelgium | Partner | EUR 0 | PIC (1.00) |
| Vib Vzw | BEBelgium | Participant | EUR 667,673 | known name (0.95) |
| Genexplain GmbH | DEGermany | Participant | EUR 249,216 | PIC (1.00) |
| Insilico Biotechnology AG | DEGermany | Partner | EUR 0 | PIC (1.00) |
| Medizinische Hochschule Hannover | DEGermany | Partner | EUR 0 | known name (0.97) |
| University of Stuttgart | DEGermany | Participant | EUR 498,433 | PIC (1.00) |
| YUMAB GmbH | DEGermany | Partner | EUR 0 | PIC (1.00) |
| BMS France | FRFrance | Partner | EUR 0 | PIC (1.00) |
| Carthera | FRFrance | Partner | EUR 0 | PIC (1.00) |
| Institut du Cerveau et de la Moelle Epiniere | FRFrance | Participant | EUR 262,876 | PIC (1.00) |
| International Brain Tumour Alliance | GBUnited Kingdom | Partner | EUR 0 | PIC (1.00) |
| Cancer Trials Ireland Company Limited By Guarantee | IEIreland | Partner | EUR 0 | PIC (1.00) |
| Information Technology for Translational Medicine (Ittm) SA | LULuxembourg | Participant | EUR 250,560 | PIC (1.00) |
| Luxembourg Institute of Health | LULuxembourg | Participant | EUR 250,560 | known name (0.95) |
| Universite du Luxembourg | LULuxembourg | Partner | EUR 0 | known name (0.95) |
| Erasmus Universitair Medisch Centrum Rotterdam | NLNetherlands | Participant | EUR 510,749 | PIC (1.00) |
| Mimetas BV | NLNetherlands | Partner | EUR 0 | PIC (1.00) |
| Pepscope BV | NLNetherlands | Partner | EUR 0 | PIC (1.00) |
| Teva Pharmaceuticals Europe B.V. | NLNetherlands | Partner | EUR 0 | PIC (1.00) |
| Champions Oncology, Inc. | USUnited States | Partner | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 23 participants from 8 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.